Stay updated with breaking news from Ellipses Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Trastuzumab deruxtecan improved PFS vs chemotherapy in pretreated, HR-positive, HER2-low or -ultralow metastatic breast cancer.
/PRNewswire/ -- Ellipses Pharma Limited ("Ellipses"), a global drug development company focused on accelerating the development of cancer treatments through an...
Scientists hail revolution in cancer medicine after discovering gene therapy which can target multiple cancers
Publicly-listed holdings in Sir Tom Hunter's West Coast Capital investment portfolio have had a tough time this past year
Ellipses EP0031/A400 granted Orphan Drug Designation from the US Food and Drug AdministrationEP0031/A400, a next generation selective RET inhibitor (SRI), is currently being investigated as a treatment option for patients with RET altered tumours Ellipses Pharma (“Ellipses”), a global drug dev...